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Purpose/Objective: To evaluate through Doppler ultrasound the 
intratumoral vascularization of uveal melanoma (UM) at diagnosis as a 
sign of tumoral activity, and to quantify its presence after treatment 
with brachytherapy. 
Materials and Methods: 50 cases of UM were treated with 
brachytherapy from July 2005 to June2010. 26 men and 24 women 
with an average age of 60. 70% melanotic, 18% amelanotic and 12% 
mixed. Location: 30% posterior, 16% postequatorial, 22% equatorial, 
20%peripheral and 12% in ciliary body. Mean basal size and apical 
thickness at diagnosis: 12.1 x 5.6 mm (SD 3.0-5.6). A 125-Iodine 
plaque was used in 70% of cases and 106-Ruthenium in 28%. 
Transpupillary thermotherapy (TTT) was associated in 10 cases. The 
apical dose was 85 Gy. Mean follow-up was of 29 months (13.7-69 
months). Duplex Doppler scans (gray scale and Doppler scans) were 
done at diagnosis and every 6months after treatment. Parameters 
evaluated: presence of intratumoral vessels, systolic peak velocity 
(SPV), end-diastolic velocity (EDV) and resistance index (RI= syst-
diast/syst). 
Results: Doppler detected intratumoral vascularization at diagnosis in 
21 of 50 cases (42%): vascularization persisted in 7 cases at 6, 12 and 
18 months. At 24 months only persisted 5/31, at 30 months 3/20, at 
36 months 1/12, at 42 months 1/6, at 48 months 1/3, at 54 months 
1/2 and at 60 months 0/1. Mean systolic peak velocity at diagnosis 
was 25.2±16.1 cm/s and 15.82±10.5 at 6 months. The treatment had 
asignificant impact on the detection of tumour vessels (p=0.035), 
controlled by age, sex, maximum tumoral diameter and tumoral 
thickness in a logistic regression model. Mean resistance index (RI) 
was lower in tumours before treatment (0.50 vs 0.59, p=0.0047). Out 
of 6 tumours with persistent signal during follow-up, 4 were in 
regression, 1 large tumour recurred and was enucleated, and another 
large one developed metastases. 8 avascular tumors at diagnosis 
experienced new vascularization during follow-up: 1 recurred and was 
enucleated and the other 7 showed ophthalmoscopic and echographic 
regression, and vascularization eventually disappeared. 4 of them 
developed neovascular glaucoma (NVG). Reduction of the apical 
thickness was more significant in initially vascularized tumors that had 
lost the Doppler signal than in tumors that remained avascular or 
vascular at 6months (p=0.365). The SPV dropped significantly at 6 
months (p=0,028) but EDVdid not (p=0.116). 
Conclusions: The non-invasive quantification of neovascular blood 
flow using pulsed Doppler for UM treated with brachytherapy offers a 
new diagnostic modality to evaluate the tumour activity. Most UM lose 
their Doppler signal in the first 6 months. Persistent intratumoral 
vascularization seems to relate to large tumours, recurrence or 
appearance of vascular congestion. The new vascularization cases can 
be explained by the persistence of old vessels, tumor recurrence or 
presence of NVG.  
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Purpose/Objective: Hilar cholangiocarcinoma (Klatskin tumours) are 
rare tumours with poor prognosis. The purpose of this work was to 
determine efficacy, toxicity, and patterns of recurrence in patients 
treated with endobiliary radiotherapy (RT) and external beam RT 
(EBRT) with chemotherapy. 
Materials and Methods: From Aug 2005 to July 2012, 65 patients with 
locally advanced non-metastatic hilar cholangiocarcinoma and were 
studied. All the patients presented with jaundice and required 
percutaneous biliary drainage. Endobiliary RT using HDR – Iridium 192 
(median dose 14 Gy/4# b.i.d), was delivered through the PTBD 
catheter which was followed by metal stenting. Twenty two (34%) 
patients received only endobiliary RT, while 27 (41%) patients after 
brachytherapy were further treated with concurr (median dose 
45Gy/25#). Sixteen (25%) patients in who were referred after metal 
stenting received Intensity modulated radiotherapy to a dose of 
57Gy/25# with concurrent Inj. Gemcitabine (300mg/mt2 weekly). 
Histopathological diagnosis was available in 50 patients (77%).  
Results: Median follow up for whole group was 7 months (range 1-31 
months). Twelve patients had complete response, 30 patients had 
partial response and 12 patients had stable disease, while 11 patients 
had locally progressive disease after radiation. Twenty one patients 
were alive at last follow up. The median overall survival (OAS) was 7 
months and one year OAS and Cancer specific survival (CSS) was 44% 
and 51% for whole group. Patients receiving endobiliary combined 
with chemoradiation or high dose chemoradiation alone had better 
survival as compared to patients receiving only endobiliary RT at 1 
year (55% vs.17%, p=0.001). The main sites of distant disease 
progression were liver and peritoneum. Thirty one patients (48%) 
developed cholangitis of which 8 patients succumbed to it. Four 
patients had late radiation toxicity, of these 3 had hematemesis due 
to duodenitis and one had radiation induced stricture at 
gastroesophageal junction requiring dilatation. 
Conclusions: These encouraging results suggest that endobiliary 
radiation in addition to chemoradiation is feasible with acceptable 
toxicity in unresectable Klatskin tumors and leads to better outcome 
as compared to those receiving only endobiliary RT alone. 
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Purpose/Objective: Keloids are challenging lesions to treat with high 
rates of recurrence. There are a multitude of treatment options 
available with various rates of success. Evidence has shown surgical 
resection followed by RT to have the highest level of local control and 
numerous reports have shown control rates of 65 – 90% with adjuvant 
external beam RT. Prior studies have demonstrated a spectrum of 
aggressiveness for keloids. Secondary keloids or lesions that have 
undergone prior resection and then recurred are often refractory to 
further treatment with higher rates of recurrence. Keloids that recur 
after combined surgery and EBRT are especially difficult cases and 
limited in therapy options. The objective of our study was to 
determine the efficacy of surgical resection of keloids followed by 
HDR brachytherapy for management of lesions at high risk for 
recurrence.  
Materials and Methods: This study is a retrospective analysis of 18 
patients representing 29 keloids found on various body sites including 
the chest wall, axilla, breast, ear, pelvis, chin, cheek, neck, back, 
shoulder, and abdomen, treated at Montefiore Medical Center 
between 1996 and 2011. Our study population consisted of mainly 
secondary lesions already treated in the past with the combination of 
surgery and EBRT, lesions treated with surgery alone, or primary 
keloids deemed to be at a high risk for recurrence due to their size 
and location. The treatment in this study consisted of complete 
surgical excision with placement of hollow brachytherapy catheters, 
immediately followed by HDR Iridium-192 brachytherapy to a total 
dose of 15Gy in 3 fractions, over 3 consecutive days, prescribed to a 
1cm depth. Endpoints assessed included recurrence rate, treatment 
complications, and side effects. 14 lesions had undergone prior 
resection(s) and external beam radiation, 6 had previously received 
surgery alone, and 9 were primary lesions. The two most common 
sites were earlobe and chest wall. The mean age at treatment was 43 
(range 23-64 years).  
Results: The mean follow up in our study was 62 months (range 12-192 
months). Analysis of the data demonstrated a recurrence-free rate of 
89.6% (26/29 lesions). Two of the recurrences had received previous 
surgery and EBRT and one was a primary keloid with no prior 
treatment. 7 patients experienced delayed wound healing but 
eventually had a full recovery. 3 patients had post-operative 
infections at the surgical site that were successfully treated. Two 
patients experienced mild intermittent parasthesias at the treatment 
site and one complained of mild pruritis post-treatment. For the other 
26 lesions, there was an improvement in keloid symptoms including 
pain, parasthesias, and pruritis. 
Conclusions: Surgical resection and adjuvant HDR Iridium-192 
brachytherapy provide excellent and enduring levels of local control 
for keloid lesions at high risk for recurrence and are well tolerated 
with acceptably minimal long term side effects with a mean follow up 
of 62 months.  
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Purpose/Objective: The aim of this study was to evaluate the 
feasibility, safety and the early clinical results of a new procedure of 
